TelevettedTELEVETTED
Menu

THE RECORD

Every change, dated and sourced.

When a company adds, removes or changes what it publishes, or when policy shifts, it goes here with the date we checked and a link to the source. Nothing is edited after the fact.

  1. AddedMEDVi

    Added to the Disclosure Index. Answers 3 of 6 questions on its own site; states served not published.

    Source ↗

  2. PriceMEDVi

    Advertises compounded semaglutide at $99 for the first month, with refills "locked in at $199."

    Source ↗

  3. FDAMEDVi

    FDA warning letter #721455 (Feb 20, 2026) on file. MEDVi says the cited site belonged to an affiliate.

    Source ↗

  4. PolicyHHS

    Peptide enforcement policy takes effect. Licensed 503A pharmacies may compound BPC-157 and five other peptides under set conditions.

    Source ↗

  5. PolicyHHS

    Announces enforcement discretion for BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon. Comments due Nov 13.

    Source ↗

  6. AddedDisclosure Index

    Launched with 9 telehealth companies, each checked against the same six questions.

Run one of these companies and something here is out of date? Request a re-check →